BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

Fourth quarter and full year revenues of €5.5 billion1 and €19.0 billion1, respectively
Full year net income of €10.3 billion and fully diluted earnings per share of €39.63 ($46.872)